Timing of Therapies
Our predecessor site BCCT summarizes the evidence regarding the effects of timing of therapies with cancer.
. Last modified on : Nov 17 2022Statins
Our predecessor site BCCT summarizes the evidence regarding statins’ effects with cancer.
. Last modified on : Nov 17 2022Rapamycin (Sirolimus)
By blocking certain functions of the mTOR enzyme, rapamycin reduces cell growth. It therefore may be useful in treating or preventing proliferative diseases, including cancer.
. Last modified on : Feb 27 2023Propranolol and Other Beta Blockers
Our predecessor site BCCT summarizes the evidence regarding propranolol’s and other beta blockers’ effects with cancer.
. Last modified on : Nov 17 2022Non-aspirin Nonsteroidal Anti-inflammatory Drugs (NSAIDs)
Nonsteroidal anti-inflammatory drugs (NSAIDs) are used to reduce inflammation, with notable benefits in increasing survival and reducing risk of several types of cancer; expert consensus is that the risks of harm from using these drugs long-term for prevention are greater than the benefits for many people.
. Last modified on : Mar 14 2023Metformin
Metformin, used to manage diabetes, shows some benefits in lower risks of cancer and better survival, mostly among people with diabetes or high blood sugar.
. Last modified on : Mar 23 2023Low-dose Naltrexone
This prescription drug is used off-label in low doses to treat people with cancer, with notable but very preliminary successes in cases where the cancers were difficult-to-treat or quite advanced.
. Last modified on : Jan 04 2023Hyperthermia
Our predecessor site BCCT summarizes the evidence regarding hyperthermia’s effects with cancer.
. Last modified on : Nov 17 2022Copper Chelation
Copper promotes the formation of blood vessels, including those that supply tumors. Depleting copper can deprive the tumor of its suppliers.
. Last modified on : Mar 14 2023Cimetidine
Our predecessor site BCCT summarizes the evidence regarding cimetidine’s off-label effects with cancer.
. Last modified on : Mar 14 2023